Phytopharmacy & Phytomedicine
Phase 6 — Regulatory Compliance & Herbal Drug Submission
6.13 Chapter Summary
Common Interview and Viva Questions

Common Interview and Viva Questions

Differentiate the regulatory pathways for classical ASU medicines, patent/proprietary ASU medicines, and new phytopharmaceutical drugs in India.What is...

Phytopharmacy & PhytomedicinePhase 6 — Regulatory Compliance & Herbal Drug Submission6.13 Chapter Summary1 min readUpdated 2026-07-11
  • Differentiate the regulatory pathways for classical ASU medicines, patent/proprietary ASU medicines, and new phytopharmaceutical drugs in India.
  • What is Schedule T and what does it require of an ASU drug manufacturer?
  • Distinguish GMP from GLP as applied to herbal drug development.
  • What information is documented in CTD Module 3.2.S for a herbal drug substance?
  • Explain the role of the Traditional Knowledge Digital Library in preventing biopiracy.
  • Describe the traditional-use evidence duration required under the EU Traditional Herbal Medicinal Products Directive.

Related Topics